Autotaxin as a marker for liver fibrosis in chronic HCV patients

Diagnostic Value of Serum Autotaxin Levels in Liver Fibrosis in Children with Chronic Hepatitis

Non-invasive Evaluation of Liver Fibrosis Changes in Patients with Chronic ‎Hepatitis C after Directly Acting Antiviral Drugs

Liver Fibrosis Assessment in Cases of Chronic Hepatitis C after Direct Acting Antivirals Therapy using Aspartate Aminotransferase to Platelet Ratio Index and Transient Elastograph

Soluble CD163 as a surrogate marker of fibrosis regression in chronic HCV patients receiving direct antiviral agents

Non-Invasive Markers for Liver Fibrosis in Chronic HCV Patients

ASSESSMENT OF SERUM AUTOTAXIN AS NOVEL BIOMARKER OF LIVER CIRRHOSIS

Assessment of Degree of Fibrosis in Chronic Hepatitis C Virus Patients Treated with Direct Acting Antiviral Agents

Noninvasive markers for staging fibrosis in chronic hepatitis B patients

Hepatocellular Regeneration and Necrosis Markers in Chronic HCV Patients under Sofosbuvir-Based Regimen